Apimeds Pharmaceuticals US (APUS) is planning to raise $20 million in an initial public offering on the week of February 24th, IPO Scoop reports. The company will be issuing 4,500,000 shares at ...

Licious was valued at $1.5 billion in its last funding round in 2023 and counts Avendus Capital Pvt., and Kotak Investment ...

Goldman Sachs has abandoned a pledge to only take public companies with a certain number of diverse board members, underscoring the increasingly harsh environment in the US around diversity programmes ...